Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL :

Over 40 sites (U.S. and Canada) have agreed to participate in the LEVEL study LEVEL is a randomized, controlled Phase 3 trial of 152 patients, and will...

Related Keywords

Finland , Canada , Ukraine , United States , America , American , Chris Giordano , John Fraunces , Brian Mullen , Orion Corporation , Company Phase , Nasdaq Stock Market , Nasdaq , Drug Administration , Tenax Therapeutics Inc , Lifesci Advisors , Exercise Limitation , Chief Executive Officer , North American , North America , Stuart Rich , Chief Medical Officer , Tenax Therapeutic Phase , Tenax Therapeutic , Sci Advisors , Nasdaq Tenx , Tenax Therapeutics ,